Science Explorer Back to mapMap
Institution · The Hepatitis C Trust

Most cited papers from The Hepatitis C Trust

What are the most cited papers from The Hepatitis C Trust?

The most cited paper from The Hepatitis C Trust is "MAIT cells are activated during human viral infections" (Bonnie van Wilgenburg et al., 2016), with 532 citations. Next come "Genome-to-genome analysis highlights the effect of the human innate and adaptive immune systems on the hepatitis C virus" (151) and "Interferon lambda 4 impacts the genetic diversity of hepatitis C virus" (147).

Showing 50 of 58 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#Paper
1 MAIT cells are activated during human viral infections Bonnie van Wilgenburg et al. · Nature Communications Open access 23 Jun 2016 532
2 Genome-to-genome analysis highlights the effect of the human innate and adaptive immune systems on the hepatitis C virus M. Azim Ansari et al. · Nature Genetics Open access 10 Apr 2017 151
3 Interferon lambda 4 impacts the genetic diversity of hepatitis C virus M. Azim Ansari et al. · eLife Open access 3 Sep 2019 147
4 Internet Interventions for Long-Term Conditions: Patient and Caregiver Quality Criteria Cicely Kerr, Elizabeth M. Murray, Fiona A. Stevenson et al. · Journal of Medical Internet Research Open access 28 Jul 2006 133
5 Prevalence of chronic viral hepatitis in people of south Asian ethnicity living in England: the prevalence cannot necessarily be predicted from the prevalence in the country of origin G. M. Kabir Uddin et al. · Journal of Viral Hepatitis 9 Dec 2009 110
6 Hepatitis C: The beginning of the end—key elements for successful European and national strategies to eliminate HCV in Europe George Papatheodoridis et al. · Journal of Viral Hepatitis Open access Mar 2018 90
7 The State of Hepatitis B and C in the Mediterranean and Balkan Countries: Report from a Summit Conference Angelos E. Hatzakis et al. · Journal of Viral Hepatitis Open access 5 Jul 2013 75
8 Harm reduction and viral hepatitis C in European prisons: a cross-sectional survey of 25 countries Rob Bielen, Samya R. Stumo, Rachel Halford et al. · Harm Reduction Journal Open access 11 May 2018 67
9 Barriers and facilitators to hepatitis C screening and treatment for people with lived experience of homelessness: A mixed‐methods systematic review Martha Paisi, Neeltje M. T. H. Crombag, Lorna Burns et al. · Health Expectations ReviewOpen access 3 Dec 2021 65
10 Late presentation of chronic viral hepatitis for medical care: a consensus definition on behalf of the European consensus working group on late presentation for Viral, Stefan Mauss, Stanislas Pol et al. · BMC Medicine Open access 2 May 2017 57
11 Impact of Hepatitis C Treatment as Prevention for People Who Inject Drugs is sensitive to contact network structure Cornelia Metzig, Julian Surey, Marie Francis et al. · Scientific Reports Open access 8 May 2017 45
12 The Hepatitis C Awareness Through to Treatment (HepCATT) study: improving the cascade of care for hepatitis C virus‐infected people who inject drugs in England Graham I. Harrison et al. · Addiction Open access 29 Jan 2019 44
13 Finding the undiagnosed: a qualitative exploration of hepatitis C diagnosis delay in the United Kingdom Magdalena Harris, Emma Ward, Charles Gore · Journal of Viral Hepatitis Open access 29 Feb 2016 41
14 Addressing barriers to the prevention, diagnosis and treatment of hepatitis B and C in the face of persisting fiscal constraints in Europe: report from a high level conference George Papatheodoridis et al. · Journal of Viral Hepatitis 26 Jan 2016 39
15 Analysis of the UK Government’s 10-Year Drugs Strategy—a resource for practitioners and policymakers Adam Holland et al. · Journal of Public Health Open access 29 Oct 2022 36
16 Addressing HCV Infection in Europe: Reported, Estimated and Undiagnosed Cases Simona Merkinaite, Jeffrey Victor Lazarus, Charles Gore · Central European Journal of Public Health Open access Sep 2008 34
17 Viral genome wide association study identifies novel hepatitis C virus polymorphisms associated with sofosbuvir treatment failure David A. B. Smith et al. · Nature Communications Open access 20 Oct 2021 23
18 The HepTestContest: a global innovation contest to identify approaches to hepatitis B and C testing Joseph D. Tucker, Kathrine A. Meyers, John Best et al. · BMC Infectious Diseases Open access Nov 2017 23
19 Peer support for people living with hepatitis B virus—A foundation for treatment expansion Louise Downs et al. · Journal of Viral Hepatitis Open access 26 May 2024 21
20 Improving uptake of hepatitis B and hepatitis C testing in South Asian migrants in community and faith settings using educational interventions—A prospective descriptive study Claire Kelly, Marinos Pericleous, Ayesha Ahmed et al. · International Journal of Infectious Diseases Open access 27 Aug 2020 18
21 Cost-Effectiveness of One-Time Birth Cohort Screening for Hepatitis C as Part of the National Health Service Health Check Program in England Jack Williams, Alec H. Miners, Ross Harris et al. · Value in Health Open access 19 Aug 2019 15
22 Interactive health communication applications for chronic disease: Patient and carer perspectives Cicely Kerr, Elizabeth M. Murray, Fiona A. Stevenson et al. · Journal of Telemedicine and Telecare Jul 2005 15
23 Reimbursing incarcerated individuals for participation in research: A scoping review Andrea Mambro, Avideh Afshar, Frédéric Leone et al. · International Journal of Drug Policy 17 Dec 2023 14
24 United Kingdom National Guideline on the Management of the viral hepatitides A, B and C 2015 Gary Brook, Sanjay R. Bhagani, Ranjababu Kulasegaram et al. · International Journal of STD & AIDS 7 Jan 2016 14
25 Barriers and advocacy needs for hepatitis C services in prisons: Informing the prisons hepatitis C advocacy toolkit Shelley Walker, Lok Bahadur Shrestha, Andrew R. Lloyd et al. · International Journal of Drug Policy Open access 15 Mar 2024 13
26 Safe inhalation pipe provision (SIPP): protocol for a mixed-method evaluation of an intervention to improve health outcomes and service engagement among people who use crack cocaine in England Magdalena Harris, Jenny Scott, Vivian D. Hope et al. · Harm Reduction Journal Open access 23 Jan 2024 12
27 Impact of 5 years of hepatitis C testing and treatment in the North East of England prisons Amy L Johnson, Jessica Shearer, Craig J. Thompson et al. · Journal of Viral Hepatitis Open access 12 Sep 2023 12
28 Best practice guidelines for viral hepatitis service delivery in prisons Yumi Sheehan, Akhil Garg, Julia Sheehan et al. · The Lancet Infectious Diseases Open access 2 Dec 2025 11
29 Results of a Model of Delivering Hepatitis C Care in a Homeless Metropolitan Population in England María Fernanda Guerra Veloz, Khin Han, Kathryn Oakes et al. · The American Journal of Gastroenterology 30 Sep 2022 11
30 The UK Government must help end Scotland's drug-related death crisis James Quan Nicholls, Shirley Cramer, Steve Ryder et al. · The Lancet Psychiatry Open access 16 Aug 2019 11
31 Development and optimisation of a reception testing protocol designed to eliminate HCV in the UK prison population Emily Mongale, Samantha Allen, Iain Brew et al. · JHEP Reports Open access 16 Oct 2023 10
32 Strategic treatment optimization for HCV (STOPHCV1): a randomised controlled trial of ultrashort duration therapy for chronic hepatitis C Graham Cooke et al. · Wellcome Open Research Open access 29 Jul 2021 10
33 Impact and cost-effectiveness of scaling up HCV testing and treatment strategies for achieving HCV elimination among people who inject drugs in England: a mathematical modelling study Zoë Ward et al. · The Lancet Regional Health - Europe Open access 12 Dec 2024 9
34 Chronic hepatitis C elimination prison initiative: HCV‐intensive test and treat, a whole prisoner population HCV test‐and‐treat program in England Rachel Halford, Lee A. Christensen, Sean Cox et al. · Health Science Reports Open access Dec 2023 9
35 Impact of Treatment Attributes of Peginterferon for Hepatitis C on Quality of Life and Treatment Preference Cicely Kerr, Andrew J. Lloyd, Shehzad Ali et al. · Health Outcomes Research in Medicine 6 Jun 2012 5
36 Highly replicating hepatitis C virus variants emerge in immunosuppressed patients causing severe disease Paul Rothhaar et al. · Nature Communications Open access 7 Dec 2025 4
37 Co-designing the INHSU Prisons Hepatitis C Advocacy Toolkit using the Advocacy Strategy Framework Shelley Walker, Olivia R. Dawson, Yumi Sheehan et al. · International Journal of Drug Policy Open access 30 Oct 2024 4
38 What is the impact of a Hepatitis C ‘test, trace and treat’ pilot using peer workers? A Sabin Caroline, Mcque Kate, Mark Roberts et al. · Journal of Viral Hepatitis Open access 18 Sep 2023 4
39 Prospective evaluation of the impact of repeated whole prison testing for hepatitis C Naw April Phaw, Aung Min Thant, Craig J. Thompson et al. · BMJ Open Gastroenterology Open access Feb 2025 3
40 I-COPTIC: Implementation of community pharmacy-based testing for hepatitis C: Delphi consensus protocol Charlotte Cook, Leila Reid, STUART K. SMITH et al. · International Journal of Pharmacy Practice Open access 23 Aug 2022 3
41 Nobody Left Outside (NLO) Checklist: Improving access to healthcare for vulnerable and underserved groups Jeffrey Victor Lazarus, Mario Cascio, Rachel Halford et al. · International Journal of Integrated Care Open access 8 Aug 2019 3
42 Peer Interventions for Hepatitis C Testing and Treatment in OECD Countries: A Systematic Scoping Review Sorcha Daly, Leila Reid, Ryan Malcolm Buchanan et al. · Journal of Viral Hepatitis Open access 23 Jan 2026 2
43 Cost-Effectiveness Analysis of Baseline Testing for Resistance-Associated Polymorphisms to Optimize Treatment Outcome in Genotype 1 Noncirrhotic Treatment-Naïve Patients With Chronic Hepatitis C Virus Christopher G. Fawsitt et al. · Value in Health Open access 24 Oct 2019 2
44 Internet Interventions or Patient Education Web Sites? – Author’s Reply Cicely Kerr, Elizabeth M. Murray, Fiona A. Stevenson et al. · Journal of Medical Internet Research Open access 29 Sep 2006 2
45 Response from Hepatitis C Trust, BASL, BIA, BVHG, BSG, and BHIVA to article asking whether widespread screening for hepatitis C is justified Graham R. Foster, Charles Gore, Mark James Hudson et al. · BMJ Open access 24 Feb 2015 2
46 Risk prediction models for targeted testing of HIV, hepatitis B and hepatitis C: a systematic review and meta-analysis Werner Leber et al. · BMC Infectious Diseases ReviewOpen access 25 Nov 2025 1
47 Lived experience workers in prisons increase health engagement & care Lynette Reid, Sara Jane Cox, Rachel Halford et al. · European Journal of Public Health Open access Oct 2025 1
48 Peer‐Delivered Outreach With Rapid Treatment Pathways for Hepatitis C Testing and Treatment Among Unhoused People Gabriele Vojt, Philippe Bonnet, Jenny Scott et al. · Journal of Viral Hepatitis Open access 15 Sep 2025 1
49 Co‐creating and implementing a novel pre‐conference event to promote equity and inclusivity among academic researchers and people who use drugs M. J. Stowe, Louise Hansford, Rachel Halford et al. · Drug and Alcohol Review Open access 27 May 2024 1
50 The implementation of a hepatitis C testing service in community pharmacies: I-COPTIC consensus statement Carl Cook et al. · Public Health Open access 22 May 2024 1

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.